---
title: "Reducing Opioid Morbidity and Mortality"
layout: navigation
agency_dir: health_and_human_services

#twitter and blog image
image: "/img/agency/Health_and_Human_Department_Seal.png"

#twitter variables
summary: summary
description: Develop and implement an enterprise-wide data governance model to enable more efficient processes for sharing inter-agency data.
---

<aside class="usa-width-one-fourth usa-layout-docs-sidenav">
    <ul class="usa-sidenav-list">
        <li>
            <a href="../health-and-human-services/">Department of Health and Human Services</a>
        </li>
        <li>
            <a class="usa-current">Agency Priority Goals</a>
            <ul class="usa-sidenav-sub_list">
                <li>
                    <a href="../health_and_human_services/APG_hhs_1.html">Ending the HIV Epidemic</a>
                </li>
                <li>
                    <a href="../health_and_human_services/APG_hhs_2.html">Kidney Care</a>
                </li>
                <li>
                    <a class="usa-current" href="../health_and_human_services/APG_hhs_3.html">Reducing Opioid Morbidity and Mortality</a>
                </li>
                <!--            <li>-->
                <!--                <a href="../health_and_human_services/APG_hhs_4.html">Serious Mental Illness</a>-->
                <!--              </li>-->
                <!--  <li>   <a href="../health_and_human_services/APG_hhs_5.html">Provider Burden</a>
                   </li>
                   <li>
                        <a href="../health_and_human_services/APG_hhs_6.html">Serious Mental Illness</a>
                      </li>-->

            </ul>
    </ul>
</aside>
     <div class="usa-width-three-fourths usa-layout-docs-main_content">
      <h1>Department of Health and Human Services &nbsp;<a href="https://www.hhs.gov/" target="_blank"><img src="../img/agency/Health_and_Human_Department_Seal.png" alt="HHS seal" align="center" width="87"> </a></h1>
       <h2 id="section-heading-h2">{{page.title}}</h2>
         <p><b>Goal Leaders:</b></p>
         <table style="width:100%">
            <tr>
            <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="Placeholder headshot"  width="100px" ></td>
            <td width="83%" align="left">Brett Giroir, M.D., Assistant Secretary for Health </td>
            </tr>
           <tr>
               <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="Placeholder headshot"  width="100px" ></td>
               <td width="83%" align="left">Elinore F. McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Abuse</td>
           </tr>
           <tr>
               <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="Placeholder headshot"  width="100px" ></td>
               <td width="83%" align="left">Nora D. Volkow, M.D., National Institute on Drug Abuse</td>
           </tr>
      </table>
          <!--<p><b>Deputy Goal Leader: </b>Rashida Dorsey, ASPE</p>-->
            <p><b>Goal Statement:</b> Reduce opioid-related morbidity and mortality through: 1) improving access to prevention, treatment and recovery support services; 2) targeting the availability and distribution of overdose-reversing drugs;    3) strengthening public health data and reporting; 4) supporting cutting-edge research; and 5) advancing the practice of pain management. Starting from the baseline of September 30, 2019, by September 30, 2021:
            <ol>
                <li>Treatment—Increase uptake of medications for the treatment of opioid use disorder:</li>
                    <ul>
                        <li>By 15 percent the number of unique patients receiving prescriptions for buprenorphine in U.S. outpatient retail pharmacies (excluding implantable or long-acting injection products). </li>
                        <li>By 100 percent the number of prescriptions for long-acting injectable or implantable buprenorphine from retail, long-term care, and mail-order pharmacies in the U.S.</li>
                        <li>By 25 percent the number of prescriptions for extended-released naltrexone from retail, long-term care, and mail-order pharmacies in the U.S. </li>
                        <li>By 57 percent the number of providers with a DATA 2000 waiver authorizing buprenorphine prescribing for opioid use disorder treatment.</li>
                    </ul>
                <li>Overdose intervention—Increase availability and access to overdose-reversing drugs: </li>
                    <ul>
                        <li>By 50 percent the number of prescriptions dispensed for naloxone in U.S. outpatient retail and mail-order pharmacies.</li>
                    </ul>
            </ol></p>
  <!--<p><strong>Implementation Action Plans will be available with the Q1 FY 2018 performance update.</strong></p>  -->
<!--  <div class="usa-grid usa-graphic_list-row">
    <div class="usa-width-one-half usa-media_block">
      <p><img src="../img/PDF_icon.png" alt="pdftest" style="float:left;width:50px;align:bottom;"><a class="usa-external_link" target="_blank" href="FY2019_June_Agriculture_Improving_Customer_Experience_at_USDA.pdf">June 2019</a></p>
     </div>-->
     <p><b>Goal Action Plans & Progress Updates</b></p>

         <div class="usa-width-one-half">

             <p><img src="../img/PDF_icon.png" alt="pdftest" style="float:left;width:50px;align:bottom;"><a class="usa-external_link" target="_blank" href="FY2020_june_Reducing_Opioid_Morbidity_and_Mortality.pdf">July 2020</a></p>

         </div>


